Cryoglobulinaemia Related to Sjogren's Syndrome or HCV Infection: Differences Based on the Pattern of Bone Marrow Involvement, Lymphoma Evolution and Laboratory Tests After Parotidectomy
Overview
Affiliations
Objective: The relationship of cryoglobulinaemia with lymphoproliferation of mucosa-associated lymphoid tissue (MALT) as risk factors for lymphoma evolution in SS remains to be clarified. The different biologic background of SS-related cryoglobulinaemia as compared with cryoglobulinaemia linked to HCV infection was clarified by different clinical and biologic approaches.
Methods: B-cell clonal expansion was analysed in the bone marrow of 27 consecutive cases with primary SS and mixed cryoglobulinaemia, HCV unrelated, in comparison with 55 HCV-related patients with cryoglobulinaemic vasculitis (CV) without SS. The results were related to the possible occurrence and localization of B-cell lymphoma in the single case. Secondly, the prevalence of mixed cryoglobulinaemia was investigated in 41 unselected patients with primary SS showing either parotid myoepithelial sialadenitis (MESA) or a frank B-cell non-Hodgkin's lymphoma. Thirdly, the levels of serum cryoglobulins and RF were followed in one patient with primary SS, CV and parotid B-cell lymphoma of MALT after bilateral subtotal parotidectomy.
Results: A polyclonal pattern of B expansion in the bone marrow was significantly more frequent in SS-related (19/27 cases) than in HCV-related cryoglobulinaemia (19/55) (P = 0.003). Cryoglobulins were positive in a fraction of patients with SS and malignant lymphoma or with parotid MESA (13/18 and 7/23, respectively), whereas MALT involvement by the lymphoproliferative disorder was the rule. Finally, the levels of serum cryoglobulins and RF markedly decreased in the SS patient undergoing bilateral subtotal parotidectomy.
Conclusion: Lymphoproliferation of MALT appears as the biologic background of cryoglobulinaemia in SS, differently from HCV-related cryoglobulinaemia.
Kor A, Yalcin M, Erten S, Maras Y, Firat Oguz E, Dogan I Arch Iran Med. 2024; 26(10):582-591.
PMID: 38310415 PMC: 10862092. DOI: 10.34172/aim.2023.85.
De Vita S, Isola M, Baldini C, Goules A, Chatzis L, Quartuccio L Rheumatology (Oxford). 2022; 62(4):1586-1593.
PMID: 36063040 PMC: 10072883. DOI: 10.1093/rheumatology/keac470.
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years.
Treppo E, Toffolutti F, Manfre V, Taborelli M, De Marchi G, De Vita S J Clin Med. 2022; 11(15).
PMID: 35893361 PMC: 9332163. DOI: 10.3390/jcm11154272.
Liu Y, Zhu J, Huang Y, Zhang Q, Zhao L, Yu R World J Clin Cases. 2022; 10(14):4509-4518.
PMID: 35663092 PMC: 9125287. DOI: 10.12998/wjcc.v10.i14.4509.
Sjögren syndrome: looking forward to the future.
Callegher S, Giovannini I, Zenz S, Manfre V, Stradner M, Hocevar A Ther Adv Musculoskelet Dis. 2022; 14:1759720X221100295.
PMID: 35634352 PMC: 9131387. DOI: 10.1177/1759720X221100295.